跳至主要内容
临床试验/ACTRN12615000069550
ACTRN12615000069550招募中未知

Efficacy and acceptability of oxygen versus CPAP treatment for people who have obstructive sleep apnoea known to respond to oxygen therapy

A/Prof Peter Catcheside0 个研究点目标入组 20 人开始时间: 2015年1月27日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Diagnosed with obstructive sleep apnoea (OSA)
  • - Recommended usual care with CPAP treatment by their treating physician
  • - Demonstrated positive treatment response to one night of oxygen therapy (O2 AHI <10 /hr with a =50% reduction compared to the air control night; using modified AHI scoring criteria without SaO2 signal blinding and no desaturation criteria).

排除标准

  • - Smokers (due to risk of fire with home oxygen use)
  • - Women who are pregnant or who are trying to conceive
  • - Children and/or young people (i.e. < 18 years)
  • - Central sleep apnea (central apnea index >5 /hr)
  • - Any relevant significant co-morbidity including respiratory (COPD) or psychiatric disorders likely to place the patient at higher than normal risk or likely to confound experimental treatment outcomes.
  • - Physician recommended exclusion
  • - Patient unable (e.g. language difficulties) or unwilling to consent

研究者

发起方
A/Prof Peter Catcheside

相似试验